ASCO Palliative and Supportive Care Conference Coverage
Featured Articles
(ASCO) Nov 13, 2018 - An analysis of nearly 2,800 people with non-small cell lung cancer (NSCLC) who received the immune checkpoint inhibitors nivolumab (Opdivo), pembrolizumab (Keytruda), or atezolizumab (Tecentriq) found that unexpected medical problems, known as adverse events, may be more common than reported in the initial trials...
Read Article
Latest Articles
November 15, 2018
November 14, 2018
October 24, 2018
News Commentary
There is no ASCO Palliative and Supportive Care Conference Coverage commentary.

OBR Green
There are no ASCO Palliative and Supportive Care Conference Coverage OBR Green articles.
Featured Videos
There are no ASCO Palliative and Supportive Care Conference Coverage videos.
OBR Blog
There are no ASCO Palliative and Supportive Care Conference Coverage blog entries.